Goldman Sachs Upgrades SXC Health Solutions (SXCI) to Buy, Sees 19% Upside

Goldman Sachs upgraded SXC Health Solutions (NASDAQ: SXCI) to Buy with a price target of $86 (up from $71), suggesting 19% upside.

The firm said SXC Health will benefit meaningfully near-term in the current selling season and they see opportunity as it is still underappreciated despite positive EPS revision and recent stock outperformance.

As the company has grown revenue almost 6X over the 3 years, Goldman sees it more than doubling revenue by 2015.

For an analyst ratings summary and ratings history on SXC Health Solutions click here. For more ratings news on SXC Health Solutions click here.

Shares of SXC Health Solutions closed at $72.54 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Freedom Broker Upgrades John B. Sanfilippo & Son, Inc. (JBSS) to Buy
• Marti Technologies (MRT) PT Raised to $6 at Benchmark on Stronger Growth, Improved Earnings Visibility
• Okta, Inc (OKTA) PT Raised to $170 at Cantor Fitzgerald Ahead of Q2 Results